Literature DB >> 24363332

The pertussis problem.

Stanley A Plotkin1.   

Abstract

Pertussis is resurgent, and many cases are occurring in vaccinated children and adolescents. In countries using acellular vaccines, waning immunity is at least part of the problem. This article discusses possible improvements in those vaccines.

Entities:  

Keywords:  Th1 responses; adjuvants; pertussis; pertussis toxin; waning immunity

Mesh：

Substances：

Year:  2013        PMID： 24363332     DOI： 10.1093/cid/cit934

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  38 in total

Review 1.  Vaccination of healthcare workers: A review.

Authors:  Skerdi Haviari; Thomas Bénet; Mitra Saadatian-Elahi; Philippe André; Pierre Loulergue; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors:  Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal:  Pathog Dis       Date:  2015-08-06       Impact factor: 3.166

Review 3.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

4.  Fighting pertussis re-emergence: promise from vaccination in pregnancy.

Authors:  Antonio Cassone
Journal:  Pathog Glob Health       Date:  2014-12       Impact factor: 2.894

Review 5.  Licensed pertussis vaccines in the United States. History and current state.

Authors:  Nicola P Klein
Journal:  Hum Vaccin Immunother       Date:  2014-11-06       Impact factor: 3.452

6.  Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters.

Authors:  Ricardo da Silva Antunes; Mariana Babor; Chelsea Carpenter; Natalie Khalil; Mario Cortese; Alexander J Mentzer; Grégory Seumois; Christopher D Petro; Lisa A Purcell; Pandurangan Vijayanand; Shane Crotty; Bali Pulendran; Bjoern Peters; Alessandro Sette
Journal:  J Clin Invest       Date:  2018-08-06       Impact factor: 14.808

7.  Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin.

Authors:  Naveen Surendran; Michael Pichichero
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

8.  Th1 versus Th2 T cell polarization by whole-cell and acellular childhood pertussis vaccines persists upon re-immunization in adolescence and adulthood.

Authors:  Tara Bancroft; Myles B C Dillon; Ricardo da Silva Antunes; Sinu Paul; Bjoern Peters; Shane Crotty; Cecilia S Lindestam Arlehamn; Alessandro Sette
Journal:  Cell Immunol       Date:  2016-05-14       Impact factor: 4.868

9.  Toward a Controlled Human Infection Model of Pertussis.

Authors:  Tod J Merkel
Journal:  Clin Infect Dis       Date:  2020-07-11       Impact factor: 9.079

10.  The Economic Value of Vaccination: Why Prevention is Wealth.

Authors: 
Journal:  J Mark Access Health Policy       Date:  2015-08-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.